Table 2 Characteristics of included studies
The first author, year | Participants T C | Gender (M/F) T C | Age (Yr) T C | Intervention T C | Duration | Outcomes | Photosensitizer | Wavelength | Time of irradiation | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pourabbas, 2023 [21] | 26 | 26 | / | / | 26‒58 | 26‒58 | aPDT + CMD | CMD | 3 months | ①② | A | 805 nm | 60s |
Aldosari, 2023 [17] | 24 | 23 | 14/10 | 12/11 | 50.3 ± 6.7 | 52.1 ± 5.1 | aPDT + CMD | CMD | 12 weeks | ①②③ | / | 660 nm | 60s |
Javed,2017 [20] | 28 | 26 | 28/0 | 26/0 | 50.6 ± 0.8 | 52.2 ± 0.5 | aPDT + CMD | CMD | 12 weeks | ①②③ | B | 660 nm | 10s |
Alsayed, 2023 [18] | 20 | 20 | 13/7 | 10/10 | 56. ± 6.6 | 57.5 ± 4.1 | PDT + CMD | CMD | 3 months | ①②③ | A and C | 810 nm | 60s |
Deeb, 2020 [19] | 15 | 15 | 15/0 | 15/0 | 52.6 ± 0.9 | 49.2 ± 0.13 | aPDT + CMD | CMD | 12 weeks | ①②③ | B | 660 nm | 10s |
Shetty, 2022 [23] | 17 | 17 | / | / | 42.5 ± 6.4 | 45.1 ± 3.3 | aPDT + CMD | CMD | 3 months | ①③ | C | 660 nm | 60s |
Al Rifaiy, 2018 [16] | 20 | 18 | 20/0 | 18/0 | 33.6 ± 2.8 | 35.4 ± 2.1 | aPDT + CMD | CMD | 12 weeks | ①②③ | C | 670 nm | 60s |